GO
Loading...

Pharma inversion deals

Friday, 18 Jul 2014 | 5:16 PM ET

AbbVie reached an agreement to buy Shire for $54 billion. CNBC's Meg Tirrell reports this is the largest inversion yet, and shares which pharmaceutical companies could become takeout targets.